Overview
The NIH Common Fund was enacted into law by Congress through the 2006 NIH Reform Act to support cross-cutting, trans-NIH programs that require participation by at least two NIH Institutes or Centers (ICs) or would otherwise benefit from strategic planning and coordination. The requirements for the Common Fund encourage collaboration across the ICs while providing the NIH with flexibility to determine priorities for Common Fund support.
To date, the Common Fund has been used to support a series of short term, exceptionally high impact, trans-NIH programs known collectively as the NIH Roadmap for Medical Research.
The NIH Common Fund is an innovative approach to accelerate fundamental discovery and translation of that knowledge into effective prevention strategies and new treatments. The strategic initiatives to be funded under the NIH Common Fund will address critical roadblocks and knowledge gaps that currently constrain rapid progress in biomedical research. They will synergize the work of many NIH Institutes and Centers, and collectively represent a unique effort that no single or group of Institutes or Centers or other entity can do, but are the responsibility of the NIH as a whole.
Funding Opportunities:
New Common Fund Programs
-
Global Health - H3 Africa
- Program Contacts: Diane Lawrence, Joni Rutter, Louise Wideroff
- Funding Opportunities
-
HMO Collaboratory
- Program Contact: Sara Duffy
- Meetings
-
Health Economics
- Program Contact: Sara Duffy
- Funding Opportunities
-
Regulatory Science
- Program Contact: Christine Colvis
- Funding Opportunities
-
Single Cell Analysis
- Program Contact: Da-Yu Wu
- Funding Opportunities
-
Protein Capture Reagents
- Program Contact: Christine Colvis
- Funding Opportunities
- Meetings
Initiatives and Funding Opportunities
Programs with Ongoing FOA Activity
-
Molecular Libraries and Imaging
- Program Contact: Christine Colvis, Isabelle Thibau
- Funding Opportunities
- Meetings
-
Human Microbiome Project
- Program Contact: Jag Khalsa
- Funding Opportunities
- Meetings
-
Epigenomics
- Program Contacts: John Satterlee, Joni Rutter, Mark Caulder,
- Funding Opportunities
- Epigenomics Data Access Policies
- Meetings
-
Genotype-Tissue Expression (GTEx)
- Program Contacts: John Satterlee
- Funding Opportunities
- Meetings
- High Risk Research
-
Clinical Research Training
- Program Contact: Betty Tai
-
Translational Research
- Program Contact: David J. McCann
-
PROMIS (Patient Reported Outcomes Measurements Information Systems)
- Program Contact: Thomas Hilton, Cecelia Spitznas
- Funding Opportunities
-
National Institutes of Health Rapid Access to Interventional Development (NIH-RAID) Program
- Program contact: Jane Acri, Nathan Appel
- Funding Opportunities
-
Science of Behavior Change
- Program Contact: Lisa Onken
- Funding Opportunities
- Meetings
-
Library of Integrates Network-Based Cellular Signatures (LINCS)
- Program Contact: Christine Colvis
- Funding Opportunities
- Meetings
-
Knockout Mouse Phenotyping
- Program Contact: Jonathan Pollock
- Funding Opportunities
Programs No Longer Soliciting Applications
-
Building Blocks, Biological Pathways, and Networks
- Program Contact: Christine Colvis
- Funding Opportunities
- Meetings
-
Structural Biology
- Program Contacts: Rao Rapaka, Christine Colvis
- Funding Opportunities
- Meetings
-
Nanomedicine
- Program Contact: Tom Aigner
- Funding Opportunities
- Meetings
-
Interdisciplinary Research
- Program Contacts: David Shurtleff, Mynda Lynch, Lisa Onken
- Funding Opportunities
- Meetings
-
Bioinformatics and Computational Biology
- Program Contact: Karen Skinner
- Funding Opportunities
- Meetings
Featured Publication
Mentoring: A Guide for Drug Abuse Researchers
Discusses the importance of quality mentorship in drug abuse research and offers suggestions for creating a successful mentor and mentee relationship.